Fundamentals

Valuation

Metric	Q3	Q4	Δ in %
EV/EBITDA	-54.83	-128.52	284.52
Graham Fair Price	40.84	2.49	1.77
PEG	-81.95	0.01	-0.08
Price/Book	-36.38	0.09	0.13
Price/Cash Flow	-67.14	0.23	0.70
Prices/Earnings	-68.19	1.45	4.54
Price/Sales	-82.87	0.15	0.90
Price/FCF	-67.14	0.23	0.70
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q3	Q4	Δ in %
Gross Profit Margin	-0.30	1.00	1.00
Operating Margin	-73.07	0.03	0.12
ROA	99.85	< 0.005	< 0.005
ROE	< 0.005	0.01	100.00
ROIC	< 0.005	< 0.005	-62.37
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q3	Q4	Δ in %
Debt QOQ	6.45	-0.14	4369.60
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	1.59	0.00	inf
EPS QOQ	-0.56	0.99	76.24
FCF QOQ	0.33	0.94	183.44
Revenue QOQ	-0.63	2.71	328.06
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q3	Q4	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.00	180757.89	100.00
Days Sales Outstanding (DSO)	0.00	10.68	100.00
Inventory Turnover	0.00	< 0.005	100.00
Debt/Capitalization	0.38	0.81	114.36
Quick Ratio	26.65	-0.22	-99.16
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q3	Q4	Δ in %
Book Value	4.34	4.32	-0.41
Cash	14.88	-14.82	-0.41
Capex	-0.01	-0.08	-497.55
Free Cash Flow	0.84	1.62	92.83
Revenue	0.65	2.41	269.77
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q3	Q4	Δ in %
Current Ratio	26.65	0.24	-99.11
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	298.79	-119.44	-60.03
Naive Interpretation	Member

06 - Financial Health · Bad

Rating